In September 2025 , Eli Lilly and Company invested $6.5 billion to build a new manufacturing facility in Houston, Texas, dedicated to producing its experimental oral GLP-1 pill, orforglipron
B12 helps reduce homocysteine levels, an amino acid linked to heart disease
Supplementing with adequate L-carnitine helps improve heart function in individuals suffering from congestive heart failure, can minimize damage after a heart attack, may reduce the pain of angina, and can help improve arrhythmias without affecting blood pressure
If you have questions, identify any inaccuracies, or would like to suggest an update, please reach out to us through our websites contact form
Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis